MYELOGENOUS LEUKEMIA IN RELAPSE

Clinical trials for MYELOGENOUS LEUKEMIA IN RELAPSE explained in plain language.

Never miss a new study

Get alerted when new MYELOGENOUS LEUKEMIA IN RELAPSE trials appear

Sign up with your email to follow new studies for MYELOGENOUS LEUKEMIA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Radiation 'Warhead' trial aims to give tough leukemia patients a fighting chance

Disease control Not yet recruiting

This study is testing a new treatment approach for adults with acute myeloid leukemia (AML) that has returned or not responded to standard therapies. It combines a targeted radiation drug with chemotherapy and low-dose whole-body radiation to prepare patients for a stem cell tran…

Matched conditions: MYELOGENOUS LEUKEMIA IN RELAPSE

Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

MYELOGENOUS LEUKEMIA IN RELAPSE

Get alerted when new MYELOGENOUS LEUKEMIA IN RELAPSE trials appear

Radiation 'Warhead' trial aims to give tough leukemia patients a fighting chance